Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
August 3, 2017
Foamix Announces Dosing of First Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101
REHOVOT, Israel, and BRIDGEWATER, New Jersey, Aug. 3, 2017 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical stage specialty pharmaceutical company focused on developing and ...
August 3, 2017
Bellerophon Announces FDA Agreement on Phase 2b Study Design for INOpulse® in Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
WARREN, N.J., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH), a clinical-stage biotherapeutics company, today announced agreement with the U.S. Food and Drug Administration ...
August 3, 2017
Genkyotex’s GKT831 Shown to Delay Tumor Growth in Multiple Preclinical Models by Targeting Cancer Associated Fibroblasts
Genkyotex (GKTX.PA) (GKTX.PA) (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announced today that data in multiple ...
August 2, 2017
Paratek Pharmaceuticals, Inc. Reports Second Quarter 2017 Financial Results and Provides Clinical Update
BOSTON, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
August 2, 2017
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
LONDON, Aug. 2, 2017 /PRNewswire/ -- Based on its recent analysis of the blood purification market, Frost & Sullivan recognizes CytoSorbents Corporation with the 2017 Global ...
August 2, 2017
Sierra Oncology to Present at the 2017 Wedbush PacGrow Healthcare Conference
VANCOUVER, Aug. 2, 2017 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) ...
August 2, 2017
VBL Therapeutics to Report Second Quarter 2017 Results on August 14
TEL AVIV, Israel, Aug. 02, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
August 2, 2017
Lipocine to Present at the Canaccord Genuity 37th Annual Growth Conference
SALT LAKE CITY, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that Dr. Mahesh Patel, Chairman, President and ...
August 2, 2017
AgeX Therapeutics Obtains $10 Million in Capital and Commences Operations
ALAMEDA, Calif.-- (BUSINESS WIRE) -- AgeX Therapeutics, Inc. (AgeX), a subsidiary of BioTime, Inc. (NYSE MKT: BTX), today reported that it has successfully raised $10 million ...
August 2, 2017
Advaxis to Present at Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
PRINCETON, N.J. -- (BUSINESS WIRE) -- Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced three ...
August 1, 2017
VALNEVA Announces Expansion of its Management Board - Strengthening Senior Management for Future Growth
Lyon (France), August 1, 2017 - Valneva SE ("Valneva" or "the Company"), a fully integrated commercial stage biotech company focused on developing innovative, lifesaving vaccines, ...
August 1, 2017
Vermillion to Present at the Canaccord Genuity 37th Annual Growth Conference on August 10th
AUSTIN, Texas, Aug. 1, 2017 /PRNewswire/ -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Valerie Palmieri, President and Chief ...
August 1, 2017
Ocera Therapeutics Reports Second Quarter 2017 Financial Results
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (OCRX), a clinical stage biopharmaceutical company focused on ...
August 1, 2017
TRACON to Report Second Quarter Company Highlights and Financial Results on August 8, 2017
SAN DIEGO, Aug. 01, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
August 1, 2017
Prothena to Report Second Quarter 2017 Financial Results on August 8
DUBLIN, Ireland, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of ...
August 1, 2017
DURECT Corporation Invites You to Join its Second Quarter 2017 Earnings Conference Call
CUPERTINO, Calif., Aug. 1, 2017 /PRNewswire/ -- In conjunction with DURECT Corporation's (DRRX) second quarter 2017 financial results press release, you are invited to listen to ...
August 1, 2017
Gemphire Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
LIVONIA, Mich., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), today announced that on July 31, 2017, the Compensation Committee of its Board ...
August 1, 2017
Zealand Pharma A/S commences initial public offering of American Depositary Shares in the United States
Copenhagen, August 1, 2017 - With reference to the company announcement no. 25/2017, dated July 6, 2017, regarding the initial public filing of registration statement ...
August 1, 2017
Kamada Reports Financial Results for Second Quarter and First Six Months of 2017
REHOVOT, Israel, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, today announced financial results ...
August 1, 2017
CytoSorbents to Report Q2 2017 Operating and Financial Results
MONMOUTH JUNCTION, N.J., Aug. 1, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO),  CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation ...
Page 101 of 117